Cite
Sayem MA, Tomita Y, Yuno A, et al. Identification of glypican-3-derived long peptides activating both CD8. Oncoimmunology. 2015;5(1):e1062209doi: 10.1080/2162402X.2015.1062209.
Sayem, M. A., Tomita, Y., Yuno, A., Hirayama, M., Irie, A., Tsukamoto, H., Senju, S., Yuba, E., Yoshikawa, T., Kono, K., Nakatsura, T., & Nishimura, Y. (2016). Identification of glypican-3-derived long peptides activating both CD8. Oncoimmunology, 5(1), e1062209. https://doi.org/10.1080/2162402X.2015.1062209
Sayem, Mohammad A, et al. "Identification of glypican-3-derived long peptides activating both CD8." Oncoimmunology vol. 5,1 (2016): e1062209. doi: https://doi.org/10.1080/2162402X.2015.1062209
Sayem MA, Tomita Y, Yuno A, Hirayama M, Irie A, Tsukamoto H, Senju S, Yuba E, Yoshikawa T, Kono K, Nakatsura T, Nishimura Y. Identification of glypican-3-derived long peptides activating both CD8. Oncoimmunology. 2015 Aug 31;5(1):e1062209. doi: 10.1080/2162402X.2015.1062209. eCollection 2016. PMID: 26942076; PMCID: PMC4760284.
Copy
Download .nbib